When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
Repeated mass azithromycin distributions are effective in controlling the ocular strains of chlamydia that cause trachoma. However, it is unclear when treatments can be discontinued. Investigators have proposed graduating communities when the prevalence of infection identified in children decreases...
Saved in:
Main Authors: | Kathryn J Ray (Author), Thomas M Lietman (Author), Travis C Porco (Author), Jeremy D Keenan (Author), Robin L Bailey (Author), Anthony W Solomon (Author), Matthew J Burton (Author), Emma Harding-Esch (Author), Martin J Holland (Author), David Mabey (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2009-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
by: Emma Harding-Esch, et al.
Published: (2015) -
Identifying a sufficient core group for trachoma transmission.
by: Thomas M Lietman, et al.
Published: (2018) -
Risk factors for active trachoma and ocular Chlamydia trachomatis infection in treatment-naïve trachoma-hyperendemic communities of the Bijagós Archipelago, Guinea Bissau.
by: Anna R Last, et al.
Published: (2014) -
Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia.
by: Emma M. Harding-Esch, et al.
Published: (2013) -
Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
by: Emma M Harding-Esch, et al.
Published: (2013)